Facial Fat Grafting

Key Facts

• Entity type: Aesthetic and reconstructive surgical procedure (autologous fat transfer applied to the face).
• Also known as: Facial lipofilling, facial fat transfer, autologous fat injection of the face, micro-fat grafting.
• Material used: The patient's own adipose (fat) tissue, harvested by liposuction [4][3].
• Typical donor sites: Abdomen, flanks, thighs or inner knees — areas commonly treated with liposuction [4].
• Setting: Operating room or licensed surgical facility, under local anaesthesia with sedation or general anaesthesia; performed by a qualified plastic or facial surgeon [1].
• Main alternative: Dermal fillers — temporary, non-surgical volumising injections.
• Key biological limitation: Partial graft resorption; a variable proportion of injected fat does not survive, and retention rates reported in the literature vary widely [5][6] [PENDING SOURCE: specific retention percentages].
• Specific safety concern: Injection close to the eyes or nose carries a rare risk of vascular occlusion (blockage of a blood vessel by injected fat) source pending.
• Status of this page: Medical draft; expert clinical review required before publication.

Definition

Facial fat grafting is the transfer of a person's own fat from one part of the body to the face in order to replace lost soft-tissue volume, smooth contour irregularities or improve the quality of overlying skin. It belongs to the broader family of autologous fat transfer (lipofilling) procedures, in which adipose tissue is removed by liposuction, processed to separate usable fat from blood, oil and local anaesthetic fluid, and then re-injected in small aliquots into the recipient site [3][4].

Unlike a synthetic or biosynthetic implant, the grafted material is living tissue. When a graft becomes revascularised and integrates, it behaves like the surrounding fat of the recipient area; the portion that does not survive is resorbed by the body [5]. This dual behaviour — partial permanence and partial loss — is the defining clinical characteristic of the technique.

Medical and Scientific Background

Autologous fat transfer is used across several body areas, including the breast, buttocks and face, and the same core biology applies in each location [3]. Harvesting relies on liposuction, a well-established surgical technique in which a cannula connected to suction removes subcutaneous fat through small incisions [4].

Why only part of a graft survives

Transplanted fat has no immediate blood supply. In the first days after grafting, adipocytes (fat cells) at the centre of a graft parcel are dependent on diffusion of oxygen and nutrients, and ischaemia leads to cell death in a proportion of the transferred tissue. Graft survival therefore depends on rapid revascularisation and on the regenerative response of surviving cells within the adipose tissue, including adipose-derived stem or stromal cells (ADSCs), which contribute to angiogenesis, tissue remodelling and modulation of inflammation [5]. Research into fat graft survival focuses on these mechanisms and on strategies intended to improve retention, such as enrichment with cellular or platelet-derived components and modifications to harvesting and processing [5].

Cell-assisted lipotransfer and enrichment strategies

Cell-assisted lipotransfer (CAL) refers to supplementing a fat graft with a concentrated cell population — typically stromal vascular fraction or expanded adipose-derived stem cells — with the aim of improving graft retention. A systematic review of CAL efficacy has examined the published clinical evidence for this approach [6]. Findings across studies are heterogeneous in technique, outcome measurement and follow-up, and conclusions should be interpreted with that variability in mind [6][5].

Patients should be aware that "stem cell" terminology is used loosely in aesthetic marketing. Independent patient resources from the stem cell research community emphasise that most stem-cell-based interventions remain investigational, that claims should be checked against published evidence, and that regulatory status differs between countries [2].

How It Works

1. Assessment and planning. The surgeon evaluates facial volume loss, skin quality, asymmetry and the availability of donor fat, and plans the volumes and depths to be injected. As with any cosmetic surgery, suitability, expectations and the qualifications of the operating surgeon should be discussed before proceeding [1].
2. Harvesting. Fat is removed from a donor area using liposuction through small incisions, usually after infiltration of a local anaesthetic solution [4].
3. Processing. The aspirate is processed — for example by decantation, centrifugation, filtration or washing — to remove blood, oil and infiltration fluid and to produce a graft of appropriate particle size for the face. Fine ("micro" or "nano") preparations are used for superficial or delicate areas [3][5].
4. Injection. The processed fat is placed through blunt cannulas in multiple small passes and thin layers, so that each parcel of fat lies close to well-vascularised recipient tissue. This layered technique is intended to maximise the surface area available for revascularisation [5].
5. Healing and consolidation. Swelling and bruising settle over the following weeks, while graft survival is determined over the first months. Because part of the graft resorbs, the final result is assessed after that consolidation period, and some patients require a second session for additional volume [3] [PENDING SOURCE: typical timeframe and re-treatment rates for facial grafting].

Applications

• Age-related volume loss: midface and cheek flattening, temple hollowing, deflation around the jawline and chin.
• Periorbital hollowing: tear-trough and upper-eyelid hollowing, where small volumes and careful technique are required.
• Contour irregularities: depressions after trauma, surgery or infection.
• Reconstructive indications: facial asymmetry, post-oncological or post-traumatic soft-tissue deficits, and congenital conditions such as hemifacial atrophy [PENDING SOURCE: condition-specific outcome data].
• Adjunct to other procedures: fat grafting is frequently combined with facelift, blepharoplasty or skin resurfacing within the same operation.
• Skin-quality indications: improvement of scars and skin texture has been proposed, based on the regenerative properties attributed to adipose tissue and its stromal cell population [5]; clinical evidence in this area continues to develop [6].

Potential Benefits

• Autologous material. The graft is the patient's own tissue, so there is no risk of allergic reaction to a foreign filler substance [3].
• Potentially long-lasting volume. Fat that survives and revascularises becomes integrated living tissue and can persist indefinitely, in contrast to resorbable dermal fillers [3].
• Natural consistency. Integrated fat has a soft, tissue-like feel and moves with the face.
• Body contouring of the donor area. Harvesting uses liposuction, which may modestly refine the donor site, although liposuction is not a treatment for obesity or for skin laxity [4].
• Large volumes possible. Where substantial soft-tissue replacement is needed, autologous fat can provide more volume than is usually practical with injectable fillers [3].
• Possible tissue-quality effects. Adipose tissue contains stromal and stem cell populations with pro-angiogenic and remodelling activity, which is the biological rationale for reported effects on skin and scar quality [5].

Limitations

• Partial resorption. A variable share of the injected fat does not survive, so the volume seen immediately after surgery overstates the final result [3][5].
• Lower predictability than fillers. Retention differs between patients, facial regions and techniques, and outcomes depend on harvesting, processing and injection method [5][6].
• Donor site required. Patients with very little subcutaneous fat may not have enough graft material, and the donor area adds its own incisions, bruising and recovery [4].
• Not reversible. Unlike hyaluronic-acid fillers, which can be dissolved enzymatically, grafted fat cannot be removed by injection; over-correction or lumps may require surgical revision.
• Surgical procedure. Facial fat grafting involves anaesthesia, an operating facility, downtime and cost that exceed those of an office-based filler treatment [1].
• Weight-dependent volume. Grafted fat remains metabolically active tissue, so significant weight change may alter facial volume.
• Evidence gaps. Enrichment techniques such as cell-assisted lipotransfer are not yet standardised, and available studies vary in design and reporting [6][2].

Risks and Safety

General surgical and procedural risks

As with other cosmetic surgery, possible complications include bleeding, haematoma, infection, adverse reaction to anaesthesia, delayed healing, altered sensation, visible scarring at incision sites, asymmetry and dissatisfaction with the aesthetic result [1][4]. Liposuction at the donor site carries its own risks, including contour irregularity, numbness, fluid accumulation and, rarely, more serious systemic events [4].

Graft-specific risks

• Fat necrosis, oil cysts, lumps and nodules where grafted fat does not survive; these may be palpable or visible in thin facial skin [3].
• Calcifications within areas of fat necrosis [3].
• Under- or over-correction due to unpredictable retention, sometimes requiring revision [5].
• Prolonged swelling and bruising, which in the face can persist for several weeks [PENDING SOURCE: typical duration].

Vascular occlusion

The most serious specific concern with facial injection of any volumising material, including autologous fat, is inadvertent intravascular placement. Injection in regions supplied by branches communicating with the ophthalmic circulation — notably around the eyes, the tear trough, the glabella and the nose — carries a rare risk of vascular occlusion, which can cause skin necrosis or visual loss. Risk-reduction measures include blunt cannulas, low injection pressure, small aliquots, knowledge of facial vascular anatomy and thorough informed consent [PENDING SOURCE: incidence data and consensus management guidance].

Choosing a provider

Patients are advised to confirm that the surgeon is appropriately qualified and registered, that the facility is licensed for the level of anaesthesia used, and that the consultation covers realistic outcomes, alternatives, revision policy and complication management [1]. Claims about "stem cell facelifts" or regenerative enhancement should be checked against published evidence and regulatory status [2][6].

Who May and May Not Be Suitable

May be suitable

• Adults in good general health with facial volume loss and sufficient donor fat [3][4].
• People seeking a longer-lasting alternative or complement to repeated filler treatments, who accept that results are less precisely controllable.
• Patients requiring soft-tissue reconstruction after trauma, surgery or disease [PENDING SOURCE: indication-specific selection criteria].
• Non-smokers, or those able to stop smoking before and after surgery, since smoking impairs wound healing and tissue perfusion [1].
• Patients with stable body weight and realistic expectations about partial resorption and possible second sessions [5].

May not be suitable

• People with very low body fat and no adequate donor site [4].
• Patients with active infection, uncontrolled systemic disease, bleeding disorders or conditions that contraindicate anaesthesia [1][4].
• Those who are unwilling to accept a surgical procedure, donor-site recovery or the possibility of revision.
• Patients seeking treatment primarily for skin laxity or wrinkles without volume loss; fat grafting replaces volume and does not tighten skin, just as liposuction does not treat loose skin [4].
• People with unrealistic expectations, or with body dysmorphic concerns that warrant psychological assessment before cosmetic surgery [1].
• Pregnancy and breastfeeding (elective procedure; defer) source pending.

Evidence

Autologous fat transfer is a widely practised technique described in patient-facing surgical references for multiple anatomical regions [3][4]. The main scientific debate is not whether grafted fat can survive, but how reliably and how much, and how survival can be improved.

• Mechanistic research. Reviews of fat graft survival describe ischaemia-driven adipocyte loss, the role of adipose-derived stem cells in angiogenesis and remodelling, and the rationale for next-generation regenerative strategies intended to raise retention [5].
• Cell-assisted lipotransfer. A systematic review of CAL efficacy synthesises clinical studies of fat grafts enriched with adipose-derived cellular fractions; heterogeneity in protocols and outcome measures limits pooled conclusions [6].
• Outcome measurement. Reported retention depends on the measurement method used (volumetric imaging, photographic assessment, patient-reported outcomes), which contributes to the wide range of published figures [6][5] [PENDING SOURCE: face-specific volumetric retention data].
• Regulatory and interpretive caution. Independent stem cell information resources stress that cell-based enhancements are largely investigational and that marketing claims frequently outpace evidence [2].

Face-specific long-term comparative trials against dermal fillers are limited; this page should be updated as higher-quality facial data become available source pending.

Comparison: Facial Fat Grafting vs Dermal Fillers

The two options are often complementary rather than mutually exclusive: fillers may be used for fine adjustment or as a trial of volume, while fat grafting addresses larger or more durable volume replacement. Choice depends on the deficit to be corrected, willingness to undergo surgery, donor fat availability and tolerance for variability in outcome.